Real-world data on GLP-1R agonists’ safety in heart failure and CKD patients was investigated using the TriNetX Research ...
A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among ...
A mixed bag of counterintuitive results hinders trial interpretation, but experts still see actionable results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback